resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
92a431bb-182a-4f6a-92a5-4509888e2102,Nf1flox/mut; Ptenflox/wt; GFAP-Cre (FMPC),['Animal Model'],"The Nf1flox/mut; Ptenflox/wt; GFAP-Cre (FMPC) mouse model harbors Pten reduction and Nf1 loss in astroglial cells, with Nf1 inactivation and Pten reduction occurring in neuroglial progenitors at embryonic day 14.5.","['Genetics', 'Development']",prenatal,14.5,days,https://doi.org/10.1016/j.neo.2015.10.002
92a431bb-182a-4f6a-92a5-4509888e2102,Nf1flox/mut; Ptenflox/wt; GFAP-Cre (FMPC),['Animal Model'],"The FMPC mouse model was generated by intercrossing Ptenflox/flox mice with Nf1flox/flox; GFAP-Cre mice, and then mating the resulting Ptenflox/wt; Nf1flox/flox; GFAP-Cre mice with Nf1flox/mut mice.","['Genetics', 'Model Development']",,,,https://doi.org/10.1016/j.neo.2015.10.002
92a431bb-182a-4f6a-92a5-4509888e2102,Nf1flox/mut; Ptenflox/wt; GFAP-Cre (FMPC),['Animal Model'],"The FMPC mouse model develops optic gliomas, which were used to accurately recapitulate the human disease and test pharmaceutical compounds in vivo.","['Disease Model', 'Tumor Biology']",,,,https://doi.org/10.1158/0008-5472.CAN-11-4092
